Cardeas-A Randomized Double Blind, Placebo-Controlled, Parallel Group, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via The Investigational eFlow Inline System In Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia

  • Bernard, Andrew (PI)
  • Bottiggi, Anthony (CoI)
  • Chang, Phillip (CoI)
  • Culpepper, Christopher (CoI)
  • Goddard, Jesse (CoI)
  • Talley, Cynthia (CoI)
  • Tucker, Brian (CoI)
  • Procter, Levi (Former CoI)

Grants and Contracts Details

Effective start/end date2/19/142/28/17


  • Parexel International Co: $136,873.00